Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

suramin

RADIATION

radiation therapy

Trial Locations (9)

19104

University of Pennsylvania Cancer Center, Philadelphia

21231

Johns Hopkins Oncology Center, Baltimore

30322

Emory University Hospital - Atlanta, Atlanta

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

35294

University of Alabama Comprehensive Cancer Center, Birmingham

48202

Henry Ford Hospital, Detroit

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00004073 - Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter